Skip to main content
. 2019 Sep 12;34(2):274–278. doi: 10.1111/jdv.15873

Table 3.

(a) Rating of the ARA vs diagnosis of the dermatologist; (b) ARA unable to perform analysis vs diagnosis of the dermatologist

(a) Diagnosis dermatologist, n (%) Total, n
Benign naevus Atypical naevus Seb. keratosis Actinic keratosis BCC M. Bowen Solar lentigo Dermatofibroma Angioma Other benign
Rating ARA, n Green 20 (59) 4 (12) 4 (12) 0 (0) 1 (3) 0 (0) 3 (9) 2 (6) 0 (0) 0 (0) 34
Yellow 19 (63) 2 (7) 2 (7) 0 (0) 1 (3) 0 (0) 3 (10) 2 (7) 1 (3) 0 (0) 30
Red 15 (33) 1 (2) 15 (33) 1 (2) 4 (9) 1 (2) 2 (4) 3 (7) 0 (0) 3 (7) 45
Total n 54 7 21 1 6 1 8 7 1 3 109
(b) Diagnosis dermatologist, n (%) a Total, n (%)
Benign naevus Atypical naevus Seb. keratosis Actinic keratosis BCC Solar lentigo Lentigo Maligna Dermatofibroma Angioma Other benign
ARA unable to perform analysis, n 35 (39) 4 (4) 14 (16) 8 (9) 9 (10) 7 (8) 1 (1) 3 (3) 3 (3) 6 (7) 90 (100)
a

Percentage of the ARA rating that was given a specific diagnosis by the dermatologist.

Abbreviations: ARA, automated risk assessment; BCC, basal cell carcinoma.